Pliant Therapeut Rg
Biopharma innovator targeting fibrosis with oral integrin inhibitors: lead dual‑selective PK‑74809 in Phase II for pulmonary fibrosis and PSC, plus liver fibrosis and oncology candidates.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 171
- HQ: South San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.